- $5.00bn
- $5.46bn
- $1.01bn
- 72
- 18
- 74
- 55
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 487 | 397 | 371 | 648 | 1,010 |
Cost of Revenue | |||||
Gross Profit | 155 | 125 | 107 | 248 | 449 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 573 | 584 | 477 | 620 | 825 |
Operating Profit | -86.6 | -187 | -106 | 28 | 185 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -113 | -198 | -124 | -2.31 | 139 |
Provision for Income Taxes | |||||
Net Income After Taxes | -141 | -197 | -130 | -22.2 | 95.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -142 | -196 | -129 | -21.7 | 97.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -142 | -196 | -129 | -21.7 | 97.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.99 | -2.79 | -2.66 | -0.475 | 1.71 |